Aumenta le possibilità di ricevere una risposta da questo datore di lavoro
Il tuo curriculum e una lettera di presentazione personalizzati, che corrispondono esattamente a ciò che sta cercando.
Neurocrine Biosciences seeks a senior Medical Affairs professional to engage KOLs and healthcare decision makers, delivering scientific and medical presentations and supporting research programs. You will communicate complex data effectively and participate in conferences as a scientific expert.
The role emphasizes strategic leadership, cross-functional collaboration, and adherence to regulatory and ethical standards in CNS therapeutics.
We are dedicated to discovering, developing and commercializing life‑changing treatments for patients with under‑addressed neurological, psychiatric, endocrine and immunological disorders.
The company's diverse portfolio includes FDA‑approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, hyperphagia in Prader‑Willi syndrome, endometriosis* and uterine fibroids*, as well as a robust pipeline including multiple compounds in mid‑ to late‑phase clinical development across our core therapeutic areas.
For more than three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders, because you deserve brave science.
Interacts with key opinion leaders (KOLs) and healthcare decision makers to communicate and advance the scientific platform for therapeutic areas that are aligned with the Neurocrine corporate strategy.
#Neurocrine Biosciences is an EEO/Disability/Vets employer.
We are committed to building a workplace of belonging, respect, and empowerment, and we recognize there are a variety of ways to meet our requirements.
In addition, this position offers an annual bonus with a target of 30% of the earned base salary and eligibility to participate in our equity based long term incentive program.